The youngest NSCP participants (group 2) were more likely to have had a new sexual partner (Table 1), and to have had a new sexual partner without also having multiple partners (21% of group 2 vs. 10% of group

1), which was consistent with the likelihood that the sampling of these young women (i.e. their receipt of chlamydia screening) was associated with their onset of sexual activity. Chlamydia prevalence was highest in group 1 (Table 1). Within this group, those recruited through youth clinics had the highest chlamydia prevalence, of 10.5%, followed by family planning at 8.9%, and general practice at 5.8%. The prevalence of HR HPV was 34.6% (95% CI 32.6–36.7) in 16–24 year old NCSP participants (group INCB024360 ic50 1), and significantly lower

in 13–15 year old NCSP participants (group 2; 22.6% 95% CI 17.6–28.6) and in POPI participants (group 3; 18.2% 95% CI 16.1–20.5). HPV 16 and/or 18 (16/18) prevalence was 17.6% (95% CI 16.0–19.3) in group 1, and 11.5% (95% CI 7.7–16.6) and 7.2% (95% CI 5.8–8.8) in groups 2 and 3, respectively. HR HPV Inhibitor Library cost prevalence increased by year of age in samples from 13 to 24 year old NCSP participants (groups 1 and 2); from ∼20% in 14 year olds to a peak of 39% in 19 year olds, with a fairly stable, sustained high prevalence (>30%) up to 24 years of age (Fig. 2). HPV 16/18 prevalence showed a similar pattern by age to all HR HPV prevalence. No difference was found in the prevalence of HR HPV infection by ethnic group, before or after adjustment for other available potential confounders (Table 2). The highest HR HPV prevalence was found in women of black (including mixed black) ethnicity (21%) in the POPI trial and in women of white ethnicity (34%) and of black (including mixed black) ethnicity (33%) in NCSP participants. The lowest prevalence in women from both study groups was found

in women of Asian (including mixed Asian) i.e. Indian Sub continent ethnicity (Table Fossariinae 2). There was a statistically significant difference in HPV 16/18 prevalence by ethnic group in POPI participants, due to the low prevalence (0.0%) in women of Asian (including mixed Asian) ethnicity (Supplementary Table 1). Women who reported multiple sexual partners had a significantly higher risk of HR HPV and HPV 16/18 infection, before and after adjustment for available data (Table 2). A strong association with chlamydia infection was also evident for both NCSP and POPI study populations, and persisted after adjustment for known potential confounders (Table 2).